Will Remote Clinical Trials Become the New Norm?

By some counts, prescription drug costs account for 20 % of all healthcare costs.  The cost of getting a drug to market reaching well over a billion dollars and there is a growing scrutiny of money-conscious consumers. It is not hard to see why pharma companies are searching to find ways to reduce costs. Clinical[…]

Patient Centricity – 5 Steps to A Positive Sum Game

A few months ago, I had an interview with a Clinical Leader in the Boston area. We discussed the state of patient centricity in healthcare. From that conversation, I came to an interesting conclusion. Patient centricity is everywhere, but too often not from the patients’ outlook. That is to say – the patient is at[…]

5 Tips for Effective Portfolio Management

Imagine that you are Indiana Jones. A series of ancient doors lie before you. Behind one – unimaginable success, profitability, and reward. Behind the others – defeat, loss and failure. You have but a single key and too many possible doors – which to choose? Does this sound like your organization? This is the constant[…]

Top 5 Reasons Why Your Biotech Needs a Project Manager

If you work at a biotech or small pharmaceutical company, you are under the microscope. You have investors waiting for the next bit of good news to raise confidence in your hard work. Your budget is limited because all funds are being used to accumulate that new data and generate the next press release. Your[…]

Clinical Operations Process Improvement Metrics (Part V – Take the Long View)

In previous blog posts, I’ve zeroed in on two of the three main areas where companies struggle with metrics. This time, I’ll focus on the third – the use of short-sighted metrics. “Localized metrics” are metrics that measure small (individual or departmental) goals. They do not have a link to broader company objectives. This use can[…]

portfolio assessment

Laying the Foundation for Pharma Pipeline Decisions

It is well known that the days of Pharma thriving on blockbuster drugs are long gone. The drug development process is lengthy – currently spanning 15 years. And drugs on the market are coming off patent with few drugs to replace the significant revenue loss. As a result, measures to cut costs or just control[…]